Aquestive Therapeutics
AQST
#7748
Rank
S$0.56 B
Marketcap
S$4.53
Share price
-1.94%
Change (1 day)
-37.74%
Change (1 year)

Operating Margin for Aquestive Therapeutics (AQST)

Operating Margin as of November 2026 (TTM): -114.45%

According to Aquestive Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -114.45%. At the end of 2021 the company had an Operating Margin of -138.77%.

Operating Margin history for Aquestive Therapeutics from 2017 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2021-138.77%14.06%
2020-121.67%-3.38%
2019-125.92%38.34%
2018-91.02%581.09%
2017-13.36%-27.93%
2016-18.54%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
OPKO Health
OPK
-13.57%-88.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-8,391.15% 7,231.72%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.